Evaluation of the effects of pregabalin and dexamethasone coadministration on preemptive multimodal analgesia and anxiety in third molar surgeries: a triple-blind randomized clinical trial.

OBJECTIVE: To evaluate the efficacy of pregabalin and dexamethasone coadministration in preemptive analgesia and anxiety control in lower third molar surgery. MATERIALS AND METHODS: A triple-blind, split-mouth clinical trial conducted with patients divided into two groups: control group, receiving placebo and dexamethasone, and test group, receiving pregabalin and dexamethasone preoperatively. The evaluated variables were pain, measured by the Visual Analog Scale (VAS), anxiety assessed through the State-Trait Anxiety Inventory (STAI) questionnaires, hemodynamic parameters [Blood Pressure (BP), Heart Rate (HR), Oxygen Saturation (SpO2)], and sedation assessed by the Ramsay scale. RESULTS: A total of 31 patients were included. The test group exhibited a significant reduction in pain at 2,4,6,8,12,16,24, and 48 h after surgery and in the consumption of rescue analgesics. Anxiety, evaluated by STAI and VAS, showed a significant decrease in the test group (p < 0.001). Additionally, there was a significant decrease in BP at most of the assessed time points (p < 0.05) and a significant reduction in HR at two different time intervals (p = 0.003 and p = 0.009), indicating a positive effect in the test group. There was no significant difference in SpO2 between the groups. Sedation assessment revealed a significant difference at all time points favoring the test group (p < 0.05). There were no significant postoperative adverse effects. CONCLUSIONS: Pregabalin coadministered with dexamethasone demonstrated significant efficacy in controlling postoperative pain and anxiety, as well as a sedative effect. CLINICAL RELEVANCE: The coadministration of pregabalin with dexamethasone may presents potential advantages in both pain modulation and psychological well-being of individuals undergoing third molar surgeries. TRIAL REGISTRATION: Brazilian Clinical Trials Registry (REBEC), No. RBR-378h6t6.

Effect of simvastatin topical use on alveolar bone after tooth extraction: a scoping review.

OBJECTIVES: Conducting a scoping review (SR) to assess scientific evidence for topical simvastatin's impact on alveolar bone regeneration and determine its level of support for clinical applications. MATERIALS AND METHODS: This SR followed the PRISMA-ScR and OSF registries protocol; systematic searching was conducted on MEDLINE/PubMed, Cochrane, Embase, Scopus, Web of Science, and LILACS, to identify relevant articles until June 2023. Inclusion criteria covered clinical trials, case series, prospective and retrospective studies, along with in vivo investigations, involving participants of any sex and age. RESULTS: Out of 1312 identified studies, 20 (9 in vivo, 11 RCTs) met inclusion criteria. RCTs focused on third molar extraction, in vivo on mandibular incisor surgery. The majority of RCTs employed a collagen sponge and a simvastatin concentration of 10mg; conversely, most in vivo studies favored polylactide-co-glycolide and a 2 mg simvastatin concentration. RCTs had 3-month follow-ups; in vivo, studies extended to 8 weeks. Seven RCTs assessed pain outcomes, simvastatin did not significantly affect pain in six studies. Among four RCTs on postoperative swelling, only two observed a significant increase in the simvastatin group. In general, positive bone formation and the absence of adverse effects directly linked to topical simvastatin were observed across the study models. CONCLUSIONS: Intra-alveolar simvastatin post-tooth extraction has been to be shown to be effective and safe for preserving alveolar bone, with varied concentrations and carriers, with no significant adverse effects. CLINICAL RELEVANCE: This review provides critical insights into the effects of simvastatin on alveolar bone regeneration, informing potential benefits and possible challenges associated with its post-extraction application. OSF REGISTRY PROTOCOL: osf.io/q3bnf.

Nitrous oxide or midazolam to tooth extraction? a systematic review / Óxido nitroso ou midazolam para extracção dentária? uma revisão sistemática / ¿Óxido nitroso o midazolam para la extracción dental? una revisión sistemática

Aim: This systematic review aimed to evaluate the use of midazolam and nitrous oxide in conscious sedation for dental extraction procedures. Methods: A search was conducted in electronic searches Medline/PubMed, Embase, Cochrane Library, Web of Science, grey literature, and the main scientific journals in the area, following PRISMA. Booleans operators were used for the combinations of terms and the search strategy was adapted to each of the databases, ("tooth extraction" OR "molar, third" OR "tooth, impacted" OR "surgery, oral" OR "exodontics" OR "wisdom tooth" AND "nitrous oxide" OR "anesthetics, inhalation" OR "conscious sedation" OR "laughing gas" OR "moderate sedation" AND "midazolam" OR "benzodiazepines" OR "hypnotics and sedatives" OR "sedative effect"). Study Selection and Data Extraction: The inclusion criteria were parallel and crossover RCTs involving patients of any age submitted to tooth extraction at a dental office under local anesthesia. No language restrictions have been imposed until 2023. The exclusion criteria were studies involving patients submitted to extraction in the hospital setting, studies that did not measure anxiety or sedation and studies for which the full text was not available. Results: Where within the eight articles that met the eligibility criteria, no significant differences were found between the methods, in relation to sedation or anxiety. Conclusion: In conclusion, nitrous oxide and midazolam safely ensure good levels of sedation and anxiety control, being pharmacological approaches possible to be used in dental care, even in those more invasive such as, tooth extraction.

Objetivo: Esta revisão sistemática visava avaliar a utilização de midazolam e óxido nitroso na sedação consciente para procedimentos de extração dentária. Métodos: Foi realizada uma pesquisa nas pesquisas electrónicas Medline/PubMed, Embase, Cochrane Library, Web of Science, literatura cinzenta, e nas principais revistas científicas da área, seguindo o PRISMA. Foram utilizados operadores booleanos para as combinações de termos e a estratégia de pesquisa foi adaptada a cada uma das bases de dados, ("extração dentária" OU "molar, terceiro" OU "dente, impactado" OU "cirurgia, oral" OU "exodontia" OU "dente do siso" OU "óxido nitroso" OU "anestésico, inalação" OU "sedação consciente" OU "gás do riso" OU "sedação moderada" OU "midazolam" OU "benzodiazepinas" OU "hipnóticos e sedativos" OU "efeito sedativo"). Seleção do estudo e extração de dados: Os critérios de inclusão foram RCTs paralelos e cruzados envolvendo pacientes de qualquer idade submetidos a extração dentária num consultório dentário sob anestesia local. Não foram impostas restrições linguísticas até 2023. Os critérios de exclusão eram estudos que envolviam pacientes submetidos a extração no ambiente hospitalar, estudos que não mediam ansiedade ou sedação e estudos para os quais o texto completo não estava disponível. Resultados: Nos oito artigos que preenchiam os critérios de elegibilidade, não foram encontradas diferenças significativas entre os métodos, em relação à sedação ou ansiedade. Conclusão: Em conclusão, o óxido nitroso e o midazolam garantem, com segurança, bons níveis de sedação e controle de ansiedade, sendo abordagens farmacológicas possíveis de serem usadas nos cuidados odontológicos, mesmo naqueles mais invasivos como, a extração dentária.

Objetivo: Esta revisión sistemática pretendía evaluar el uso de midazolam y óxido nitroso en la sedación consciente para procedimientos de extracción dental. Métodos: Se realizó una búsqueda en las bases de datos electrónicas Medline/PubMed, Embase, Cochrane Library, Web of Science, literatura gris y en las principales revistas científicas del área, siguiendo PRISMA. Se utilizaron operadores booleanos para las combinaciones de términos y se adaptó la estrategia de búsqueda a cada una de las bases de datos, ("tooth extraction" OR "molar, third" OR "tooth, impacted" OR "surgery, oral" OR "exodontia" OR "wisdom tooth" OR "nitrous oxide" OR "anaesthetic, inhalation" OR "conscious sedation" OR "laughing gas" OR "moderate sedation" OR "midazolam" OR "benzodiazepines" OR "hypnotics and sedatives" OR "sedative effect"). Selección de estudios y extracción de datos: Los criterios de inclusión fueron ECA paralelos y cruzados que incluyeran pacientes de cualquier edad sometidos a extracción dental en un consultorio dental bajo anestesia local. No se impusieron restricciones de idioma hasta 2023. Los criterios de exclusión fueron estudios que incluyeran pacientes sometidos a extracción en el ámbito hospitalario, estudios que no midieran la ansiedad o la sedación y estudios para los que no estuviera disponible el texto completo. Resultados: En los ocho artículos que cumplían los criterios de elegibilidad, no se encontraron diferencias significativas entre los métodos con respecto a la sedación o la ansiedad. Conclusión: En conclusión, el óxido nitroso y el midazolam garantizan con seguridad buenos niveles de sedación y control de la ansiedad, siendo abordajes farmacológicos posibles de ser utilizados en la atención odontológica, incluso en aquellas más invasivas como, la extracción dentaria.

Tomographic evaluation of the effect of simvastatin topical use on alveolar bone microarchitecture, pain and swelling after mandibular third molar extraction: a randomized controlled trial.

OBJECTIVES: To evaluate the effect of a collagen sponge containing simvastatin on socket healing in terms of bone microarchitecture through tomographic analysis, pain, and swelling after impacted third molar extraction. MATERIALS AND METHODS: In this single-blind, split-mouth, randomized clinical trial, 29 patients undergoing impacted third molar extraction were allocated into two groups: (i) test group, a collagen sponge containing simvastatin was inserted within the sockets; and (ii) control group, in which sockets retained the clot. Bone volume (BV), bone volume fraction (BV/TV), trabecular thickness (Tb.Th), trabecular spacing (Tb.Sp), and gray scale were evaluated using cone beam computed tomography (CBCT) acquired immediately postoperative and 3 months after surgery. Pain, swelling, and wound healing were evaluated using the 10-point visual analogue scale, three extra-oral reference measurements, and the Landry index. RESULTS: In total, 22 participants remained in the study; no loss-to-follow-up was related to the intervention. BV and BV/TV were significantly higher at 3 months postoperatively in the test group compared with the control group and were correlated with greater bone trabeculation. Pain, edema, and the Landry index revealed a greater inflammatory response in the test group during early repair. Simvastatin contributed to bone healing, with no adverse effects or postoperative complications. CONCLUSIONS: The absorbable collagen sponge containing simvastatin improved BV, BV/TV, and trabecular bone, indicating the potential of this drug to induce the formation of autogenous bone. CLINICAL RELEVANCE: Intraosseous statins represent a promising, low-cost, and easy-to-use alternative for alveolar ridge preservation and bone regeneration. TRIAL REGISTRATION: Brazilian Registry of Clinical Trials (REBEC), No. RBR-523N7R.

Tratamento conservador de ameloblastoma sólido recidivante em paciente jovem: relato de caso / Conservative treatment for recurrent solid ameloblastoma in young patient: case report

Introdução: O ameloblastoma é um tumor odontogênico benigno, embora seja localmente agressivo. As modalidades de tratamento para o ameloblastoma podem ser classificadas em radicais ou conservadoras, contudo a determinação da técnica de eleição permanece um tema controverso. Este trabalho tem como objetivo relatar e discutir um caso de ameloblastoma recorrente, tratado de forma conservadora, com enucleação e curetagem em um indivíduo adolescente. Relato do Caso: Paciente, sexo masculino, de 12 anos, foi encaminhado ao serviço de CTBMF do Hospital Universitário Oswaldo Cruz com aumento de volume assintomático em região de parassínfise mandibular direita. Foi realizada biópsia incisional e obtido o diagnóstico de ameloblastoma. Após dois anos de descompressão, foi realizada enucleação com curetagem da lesão. Cinco anos após a intervenção, o paciente apresentou recidiva do tumor, sendo realizada nova abordagem conservadora. Em acompanhamento de sete meses, ele evoluiu assintomático e sem sinais de recidiva. Considerações Finais: A abordagem conservadora é uma alternativa viável no tratamento de ameloblastomas, em especial quando se trata de indivíduos jovens, entretanto esta deve ser seguida de um rigoroso protocolo de acompanhamento clínico e radiográfico pós-operatório... (AU)

Introduction: The ameloblastoma is a benign but localy agressive odontogenic tumour. The modalities of treatment for ameloblastoma can be classified as radical or conservative, although the determination of the preferred technique remains a controversial field. The objective of this study is to report and discuss a case of recurrent ameloblastoma treated with a conservative approach with enucleation and curettage in a young patient. Case Report: 12-years old man, referred to the service of oral and maxillofacial surgery of Oswaldo Cruz University Hospital with an asymptomatic swelling in the right mandibular parasymphysis. Incisional biopsy was performed and the diagnosis of ameloblastoma was obtained. After two years of decompression, enucleation and curettage of the lesion were performed. Five years after the intervention, the patient presented with recurrence of the tumour and a new conservative approach was performed. In a seven month follow-up, the patient presents asymptomatic and without signs of recurrence. Final Considerations: The conservative approach is a viable option in the treatment of ameloblastomas, especially in young individuals. However, it should be followed by a strict protocol of clinical and radiographic postoperative follow-up... (AU)

Prognóstico e tratamento da avulsão dentária: relato de caso / Prognosis and treatment of tooth avulsion: a case report

A avulsão dentária é um tipo de traumatismo dentoalveolar que traz grande preocupação quanto ao prognóstico do paciente. As medidas de acondicionamento de dentes avulsionados são imprescindíveis para o sucesso do tratamento. O presente artigo propõe um relato de caso de avulsão dentária abordando as principais medidas de conservação dos elementos dentários e a importância do tempo entre a avulsão e seu reimplante no alvéolo... (AU)

The tooth avulsion is a type of dentoalveolar trauma that brings great concern about the patient's prognosis. Measures of packaging of avulsed tooth are essential for a successful treatment. This article proposes a case of tooth avulsion addressing the main measures for the conservation of dental elements and the importance of time of avulsed tooth to their reimplantation in the socket... (AU)

Evaluation of inorganic bovine bone graft in periodontal defects after third molar surgery.

AIM: This study evaluated the e cacy of inorganic bovine bone graft (IBB) in periodontal defect after mandibular third molar (3M) surgery. METHODS: The authors conducted a split-mouth, prospective, randomized, blinded, placebo-controlled clinical trial involving 20 participants with a mean age of 21.60 ± 6.5 years who had symmetrical bilateral lower 3M randomly assigned to receive IBB or left empty (blooding clot). The clinical variables studied were probing depth and clinical attachment level (CAL) at preoperative and postoperative periods of 10, 30, and 60 days. Radiographic measures included the distance from the alveolar bone crest to the cementoenamel junction and the bone density at 30 and 60 days postsurgical procedure. For statistical analysis, we used the paired t-test at a level of signi cance of 5%. RESULTS: It was observed a reduction in pocket depth and CAL in both groups, but IBB did not provide better results than blooding clot (P > 0.05). On the other hand, IBB group showed an increased in the bone density, and a decrease in the periodontal defect on the distal surface of second molar (2M) after 30 and 60 days of surgery compared to the control group (P < 0.05). CONCLUSION: The use of inorganic bone graft (GenOx) did not enhance the probing depth after 3M removal. Although the radiographic ndings have showed an increase in bone density and a decrease in the periodontal defect on the distal surface of the 2M, we cannot recommend the use of IBB as a treatment for periodontal defect prevention after 3M removal.